Topic: John Teerlink
In patients with acute heart failure, treatment with an intravenous infusion of relaxin -- a natural human peptide that affects multiple vascular control pathways -- may improve clinical outcomes, according to a report published online March 29 in the The Lancet to ...
The hormone relaxin reduces shortness of breath and cardiovascular death in people with heart failure who also have high blood pressure, according to a phase 2 trial conducted in eight countries.. After 60 days, fewer people given 30 ?/kg of relaxin had ...
11/6/2007 Print E-mail An experimental kind of medication has failed as treatment for the emergency condition known as acute heart failure, a new trial finds.. "This is an investigational new drug that is an endothelin receptor blocker," explained study co-author Dr. John ...
